Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
2019 · Journal of Hematology & Oncology · 137 citations
https://doi.org/10.1186/s13045-019-0704-y
R
Ruocong Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
958
Citations
14
h-index
17
i10-index
Ruocong Zhao is an academic researcher from Shenzhen University. The author has contributed to research in topics: CAR-T cell therapy research & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 14, co-authored 29 publications.
ORCID: 0000-0002-7990-6096Papers by this author
worksIncorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells
2017 · Journal of Hematology & Oncology · 96 citations
https://doi.org/10.1186/s13045-017-0437-8
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
2022 · Cell Death and Disease · 56 citations
https://doi.org/10.1038/s41419-022-05123-x
PSCA is a target of chimeric antigen receptor T cells in gastric cancer
2020 · Biomarker Research · 40 citations
https://doi.org/10.1186/s40364-020-0183-x
Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels
2022 · Molecular Therapy — Oncolytics · 30 citations
https://doi.org/10.1016/j.omto.2022.12.003
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D
2022 · Molecular Therapy — Oncolytics · 16 citations
https://doi.org/10.1016/j.omto.2022.06.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat